alexa Identification Of New Molecular Markers For Minimal Residual Disease Assessment In Acute Leukemia Patients | 15818
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd World Congress on Cancer Science & Therapy
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Sona Pekova, Tereza Jancuskova, Radek Plachy, Jiri Stika, Lucie Zemankova, David W. Hardekopf, Thomas Liehr, Nadezda Kosyakova, Radek Cmejla, Lenka Zejskova, Tomas Kozak, Pavel Zak, Alzbeta Zavrelova, Pavlina Havlikova, Michal Karas, Annelore Junge and Christian Ramel
ScientificTracks: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.028
Abstract
Acute leukemia (AL) comprises a heterogeneous group of hematologic malignancies with varying prognoses. In light of this heterogeneity, individual patient response to treatment can be difficult to predict. Sensitive monitoring of residual leukemic cell populations (minimal residual disease - MRD) is thus very important and holds great potential for improving treatment strategies. Commonly used MRD targets include recurrent cytogenetic abnormalities and mutations in important hematological genes; unfortunately such targets are identified in majority of adult ALL patients and in only about 50 % of adult AML patients. Identification of new specific molecular markers of leukemic blasts for MRD assessment is therefore highly desirable. Our goal was to develop a unique technical approach for the identification and mapping of clone-specific chromosomal abnormalities down to the single nucleotide level using current molecular cytogenetic techniques, particularly multicolor fluorescence in situ hybridization, multicolor chromosome banding (mFISH, mBAND) and multiplex hybridization of fluorescently labeled BAC clones (BAC-FISH). Higher resolution was achieved by hybridization of fluorescent probes to combed DNA fibers (molecular combing, fiber-FISH). Another approach used for the precise identification of chromosomal breakpoints was chromosome microdissection followed by next-generation sequencing (NGS) of the dissected material. Finally, a specific Real-Time PCR assay to monitor MRD was designed. Modern technologies open new vistas in the detection and identification of unique clone-specific abnormalities in AL patients. Our work clearly suggests that walking from the chromosomal level to the nucleotide level is feasible and readily applicable for eligible AL patients, allowing its use in standard clinical practice and as a tool for personalized ?tailor-made? medicine.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version